Friday, June 2, 2023
No Result
View All Result
  • Media
Support Us
Macdonald-Laurier Institute
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • The Great Energy Crisis
    • Centre for Advancing Canada’s Interests Abroad
    • Dragon at the Door
    • Canada and the Indo-Pacific Initiative
    • The Transatlantic Program
    • DisInfoWatch.org
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Justice Report Card
    • COVID Misery Index
      • Provincial COVID Misery Index
      • Beyond Lockdown
      • COVID and after: A mandate for recovery
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Past Projects
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy Magazine
      • Inside Policy Online
      • Inside Policy Back Issues
    • Papers
    • Commentary
    • Columns
    • Books
    • Video
    • Podcasts
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • The Great Energy Crisis
    • Centre for Advancing Canada’s Interests Abroad
    • Dragon at the Door
    • Canada and the Indo-Pacific Initiative
    • The Transatlantic Program
    • DisInfoWatch.org
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Justice Report Card
    • COVID Misery Index
      • Provincial COVID Misery Index
      • Beyond Lockdown
      • COVID and after: A mandate for recovery
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Past Projects
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy Magazine
      • Inside Policy Online
      • Inside Policy Back Issues
    • Papers
    • Commentary
    • Columns
    • Books
    • Video
    • Podcasts
No Result
View All Result
Macdonald-Laurier Institute

USMCA makes intellectual-property protections great across North America: Owens, Ezell, and Saracho in the Financial Post, the Hill

June 2, 2019
in Columns, Foreign Affairs, Foreign Policy Program, In the Media, Intellectual Property Rights Strategy, Latest News, North America, Richard Owens
Reading Time: 4 mins read
A A

The USMCA will unleash innovation and make Canada and Mexico more attractive locations to conduct life-sciences R&D, write Richard Owens, Stephen Ezell, and Alberto Saracho in the Financial Post. This article also appeared in the Hill. 

By Richard Owens, Stephen Ezell, and Alberto Saracho, June 1, 2019

Canada is right to proceed now with ratification of the new NAFTA agreement — now known as the U.S.-Mexico-Canada Agreement (USMCA). The previous NAFTA has done much to reinforce trade among these natural trading partners, and we cannot abandon the great advances of the USMCA.

One of the hurdles to full ratification, however, is the objection among certain groups to some of the life-sciences, copyright and other intellectual property (IP) provisions found in USMCA’s Chapter 20. Chapter 20 is beneficial for all parties to the agreement. Canada and Mexico will greatly benefit from Chapter 20 both in internal productivity gains and gains in trade. Mexico will be able to attract more knowledge-intensive industries and activities, creating the higher-paying jobs that the country needs.

One of the most salient provisions of Chapter 20 is the required extension of data protection for biologics to 10 years. Currently, the United States exceeds this minimum requirement, at 12 years, but Canada is at only eight years and Mexico has no biologic-specific data protection. Canada and Mexico will benefit from this increase because it will make these nations more attractive locations in which to conduct life-sciences research and development and clinical trials.

A “biologic” is a large molecule drug made not from simple chemical compounding as more common drugs are, but from complex biological processes. Such drugs are new and usually expensive. Biologic drugs matter because they already account for more than 30 per cent of the global drug development pipeline, with that share growing each year.

Data protection is additional protection for a patented drug, over and above the patent protection. It works by delaying the ability of a knockoff drug to use the innovator’s clinical trial and related data to qualify for sale.

In spite of the U.S.’s current compliance with the data-protection provisions, there are protests about it. In particular, a letter was sent to the U.S. Congress from unions, medical and faith-based groups and civil-society organizations opposing additional market exclusivity for biologics. The letter argued that the USMCA would “entrench and expand prescription drug monopoly protections, thwart competition and thus undermine efforts to expand access to affordable medicines.”

While the letter expresses concerns for Canada and Mexico and other future partners in trade negotiations, it is particularly concerned that legislative initiatives that have been aimed at reducing the 12-year protections in the U.S. to as low as seven will be stymied. (Reducing data-exclusivity protections for biologics was proposed in the 2016 Price Relief, Innovation, and Competition for Essential Drugs Act). Indeed, they would be stymied. And that’s a good thing, for America’s robust IP protections for biologic drugs are a key reason the United States clearly leads the world in innovating in this vital field.

The advocacy letter is deeply misguided. Monopoly protections are the reason we have access to life-saving drugs at all. Competition between biologics and “biosimilars” is indeed useful, but competition between proprietary biologics is robust, and such competition, which is occasioned by IP protection, is far more beneficial than competition with a knockoff drug (because competition among innovators is less about price but more about bringing new-to-the-world innovations, and more effective and patient-friendly delivery mechanisms, to the fore). While 10 years of data protection may seem long, research indicates that drugs commonly take more than 12 years to recoup the investment in research that makes them possible.

Moreover, the market for biosimilars will not be the same as for generic versions of simpler, old-style drugs. It costs far more to develop and seek approval for a biosimilar and cost reductions will be in the order of 30 per cent (one study estimates eight to 43 per cent for popular biologics), not the steep discounts we see with generic pharmaceutical drugs.

The other major change for Canada is increasing the term of copyright protection to the life of the author plus another 70 years, up from life plus 50 years. There are many reasons this is good for Canada — including, in particular, access to similar protections from nations that offer them only reciprocally. Canada’s Heritage committee’s report on copyright recently recommended this change, irrespective of the USMCA requirement. Mexico already has life plus 100 years.

According to the Global Intellectual Property Center, which authored a study on the USMCA, simply to implement its provisions will bring Canada and Mexico up to 80 per cent of the standard for IP protection set by the U.S. Imagine what that can do for innovation in trade in each of our countries, for our economies, for the wellbeing of our people — all of our people.

All parties should ratify now.

Richard C. Owens is a Munk senior fellow with the Macdonald-Laurier Institute and adjunct professor at the University of Toronto Faculty of Law; Stephen Ezell is vice-president, global innovation policy, The Information Technology and Innovation Foundation in Washington, D.C.; and Alberto Saracho is president of Fundacion Idea, a public policy think tank in Mexico City.

Tags: innovationintellectual propertyNAFTARichard OwenstradeUSMCA
Previous Post

Photos and Video: Why the USMCA is good for the innovative economies of North America Panel Discussion

Next Post

China-U.S. tensions loom large as Shangri-La Dialogue addresses Asian security issues: J. Berkshire Miller in the Japan Times

Related Posts

Ukraine must be victorious, for all of our sakes: Balkan Devlen for Inside Policy
Columns

Ukraine’s right to self-defence is self-evident: Chris Alexander in the Globe and Mail

June 2, 2023
Trudeau, Ford to blame for Stellantis shakedown: Aaron Wudrick in the National Post
Columns

Trudeau, Ford to blame for Stellantis shakedown: Aaron Wudrick in the National Post

June 2, 2023
Multimedia: G7 Hiroshima Summit & Beyond
Video

Multimedia: G7 Hiroshima Summit & Beyond

June 1, 2023
Next Post
China-U.S. tensions loom large as Shangri-La Dialogue addresses Asian security issues: J. Berkshire Miller in the Japan Times

China-U.S. tensions loom large as Shangri-La Dialogue addresses Asian security issues: J. Berkshire Miller in the Japan Times

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

323 Chapel Street, Suite #300
Ottawa, Ontario, K1N 7Z2 Canada

613.482.8327

info@macdonaldlaurier.ca
MLI directory

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

  • Inside Policy Magazine
  • Annual Reports
  • Jobs
  • Privacy Policy

© 2021 Macdonald-Laurier Institute. All Rights reserved.

No Result
View All Result
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • The Great Energy Crisis
    • Centre for Advancing Canada’s Interests Abroad
    • Dragon at the Door
    • Canada and the Indo-Pacific Initiative
    • The Transatlantic Program
    • DisInfoWatch.org
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Justice Report Card
    • COVID Misery Index
      • Provincial COVID Misery Index
      • Beyond Lockdown
      • COVID and after: A mandate for recovery
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Past Projects
      • The Eavesdropping Dragon: Huawei
      • Talkin’ in the Free World with Mariam Memarsadeghi
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
      • Straight Talk
      • Labour Market Report
      • Leading Economic Indicator
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Inside Policy Magazine
      • Inside Policy Online
      • Inside Policy Back Issues
    • Papers
    • Commentary
    • Columns
    • Books
    • Video
    • Podcasts

© 2021 Macdonald-Laurier Institute. All Rights reserved.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Privacy Preference Center

Consent Management

Necessary

Advertising

Analytics

Other